The opportunity
The ideal candidate will be based out of our Parsippany, New Jersey office
As the Director, In-line Brands – Global health Economics, Value, and Outcomes, you will serve as the principal strategic and technical lead for our Neuroscience TA, primarily focused on the US market. You will develop and implement comprehensive evidence generation plans, including clinical, economic and humanistic evidence to meet the needs of different external stakeholders (Payers, HCPs, Patients/Caregivers, etc.). You will work closely with the Global TA counterpart, formulate and update the recommended function strategies including the update of the value proposition and the adaptation and training of relevant colleagues on RWE, indirect comparisons, economic models and value dossiers.
How you’ll spend your day
You will work closely with the Global TA counterpart, formulate and update the recommended function strategies including the update of the value proposition and the adaptation and training of relevant colleagues on RWE, indirect comparisons, economic models and value dossiers.
⦁ The individual will develop the evidence generation plan and provide HEOR input to the US brand planning and budgeting processes.
⦁ Lead US evidence generation needs in collaboration with other Medical team colleagues.
⦁ Work closely with Medical, Payer, Market Access, and Commercial teams to ensure that evidence generation is aligned with brand strategic objectives.
⦁ Work with external partners (CROs, External Experts, etc) to complete HEOR studies.
⦁ Provide HEOR subject area expertise to development of medical/clinical plans and studies.
⦁ Work with internal teams to ensure that the HEOR deliverables are incorporated in field communication materials.
⦁ Train field teams HEOR relevant deliverables, in collaboration with Medical Affairs/ Payer team(s) to appropriately prepare for asset launch(es).
⦁ Ability to work in a cross-functional matrix team environment and effectively communicate relevant function strategies and evidence studies and outputs.
⦁ Represent Teva before appropriate scientific, medical, regulatory, payer, patient and other meetings, when appropriate.
⦁ Keep abreast of the trends of therapeutic area, HEOR, Pricing, Reimbursement, and Market Access, and proactively address strategy changes in collaboration with global and regional teams in anticipation of these trends.
⦁ Build a network of clinical, HEOR and payer experts, including academics, policy makers, HTA representatives, reimbursement influencers and other decision-makers globally to increase the robustness of scientific studies in support of market access strategies.
⦁ Manage product project budgets and timelines.
⦁ Collaborate with scientific communications to provide HEOR input on scientific platform and develop HEOR-related scientific publications.
⦁ Design and conduct real-world evidence studies and undertake targeted or systematic literature reviews to ensure timely quantitative understanding of economic, humanistic and clinical burden of disease, disease sequelae and patient journey.
